我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Parkinson's Disease Neuroimaging Progression Initiative

Gerhard Stanley*

The Parkinson’s Disease Neuroimaging Progression Initiative (PDPNIP) is a collaborative research project aimed at advancing the understanding of Parkinson’s disease through the utilization of neuroimaging techniques. The initiative focuses on developing neuroimaging biomarkers for early detection and accurate diagnosis, tracking disease progression, exploring subtypes and variability, and uncovering the neurobiological mechanisms underlying Parkinson’s disease. By analyzing imaging data from individuals with Parkinson’s disease and healthy controls, PDPNIP aims to improve diagnostic capabilities, personalize treatment approaches, and identify potential therapeutic targets. The collaborative efforts of scientists, clinicians, and institutions worldwide contribute to the progress of Parkinson’s disease research and hold promise for enhancing patient care.